ROLES OF ENDOTHELIN RECEPTORS IN THE REGIONAL AND SYSTEMIC VASCULAR-RESPONSES TO ET-1 IN THE ANESTHETIZED GANGLION-BLOCKED RAT - USE OF SELECTIVE ANTAGONISTS

被引:32
作者
ALLCOCK, GH [1 ]
WARNER, TD [1 ]
VANE, JR [1 ]
机构
[1] UNIV LONDON ST BARTHOLOMEWS HOSP & MED COLL,WILLIAM HARVEY RES INST,LONDON EC1M 6BQ,ENGLAND
关键词
ENDOTHELIN-1; ENDOTHELIN RECEPTORS; ENDOTHELIN ANTAGONISTS;
D O I
10.1111/j.1476-5381.1995.tb15099.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 Endothelin-1 (ET-1) produces vasoconstriction, via activation of ET(A) and ET(B) receptors on vascular smooth muscle, and vasodilatation via ET(B) receptors on endothelial cells. Here we have used the ETA receptor-selective antagonist, BQ-123, the ET(B) receptor-selective antagonist, BQ-788 and the ET(A)/ET(B) receptor non-selective antagonist, PD 145065, to study the role of these receptors in mediating the haemodynamic changes induced by an infusion of ET-1 to the anaesthetized ganglion-blocked rat, 2 Infusion of ET-1 (10 pmol kg(-1) min(-1)) increased the mean arterial pressure (MAP) by 57.5 +/- 5.1 mmHg over 70 min. This presser response was reduced by about 50% by coinfusion of BQ-123 (10 nmol kg(-1) min(-1)), but was unaffected by either BQ-788 (10 nmol kg(-1) min(-1)) or PD 145065 (10 nmol kg(-1) min(-1)). 3 After infusion of ET-1 for 70 min the cardiac output had fallen from 102.6 +/- 11.3 to 55.7 +/- 7.6 ml min(-1) and the total peripheral resistance had increased from 3.24 +/- 0.6 to 10.0 +/- 0.8 mmHg ml(-1) min(-1) (per 100g body weight). BQ-123 decreased the magnitudes of these changes whereas BQ-788 potentiated them. PD 145065 was without effect. 4 ET-1 increased the vascular resistances of all the organs studied except the brain and stomach. These changes were attenuated by BQ-123 in the kidneys, skin, adrenal glands and caecum and potentiated by BQ-788 in the kidneys, small intestine, large intestine and mesentery. PD 145065 had little effect on the individual tissues. 5 Thus, BQ-123, a selective ET(A) receptor antagonist, inhibits the presser and vascular constrictor effects of ET-1 more actively than PD 145065. As BQ-788 potentiates some of the vasoconstrictor effects of ET-1 and increases the effects of ET-1 on total peripheral resistance, the predominant role of ET(B) receptors in the rat circulation is to limit the presser effects of ET-1.
引用
收藏
页码:2482 / 2486
页数:5
相关论文
共 37 条
  • [1] ALLCOCK GH, 1995, BRIT J PHARMACOL, V114, pP80
  • [2] HEMODYNAMIC AND INOTROPIC EFFECTS OF ENDOTHELIN-1 IN-VIVO
    BEYER, ME
    NERZ, S
    KRAMER, BK
    HOFFMEISTER, HM
    [J]. BASIC RESEARCH IN CARDIOLOGY, 1994, 89 (01) : 39 - 49
  • [3] THE ENDOTHELIN ET(B) RECEPTOR MEDIATES BOTH VASODILATION AND VASOCONSTRICTION INVIVO
    CLOZEL, M
    GRAY, GA
    BREU, V
    LOFFLER, BM
    OSTERWALDER, R
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 186 (02) : 867 - 873
  • [4] PATHOPHYSIOLOGICAL ROLE OF ENDOTHELIN REVEALED BY THE 1ST ORALLY-ACTIVE ENDOTHELIN RECEPTOR ANTAGONIST
    CLOZEL, M
    BREU, V
    BURRI, K
    CASSAL, JM
    FISCHLI, W
    GRAY, GA
    HIRTH, G
    LOFFLER, BM
    MULLER, M
    NEIDHART, W
    RAMUZ, H
    [J]. NATURE, 1993, 365 (6448) : 759 - 761
  • [5] CODY WL, 1993, MED CHEM RES, V3, P154
  • [6] MEDIATION VIA DIFFERENT RECEPTORS OF THE VASOCONSTRICTOR EFFECTS OF ENDOTHELINS AND SARAFOTOXINS IN THE SYSTEMIC CIRCULATION AND RENAL VASCULATURE OF THE ANESTHETIZED RAT
    CRISTOL, JP
    WARNER, TD
    THIEMERMANN, C
    VANE, JR
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1993, 108 (03) : 776 - 779
  • [7] DEGOUVILLE ACL, 1990, J PHARMACOL EXP THER, V252, P300
  • [8] DENUCCI G, 1988, P NATL ACAD SCI USA, V85, P9797
  • [9] CLEARANCE OF CIRCULATING ENDOTHELIN-1 BY ET(B) RECEPTORS IN RATS
    FUKURODA, T
    FUJIKAWA, T
    OZAKI, S
    ISHIKAWA, K
    YANO, M
    NISHIKIBE, M
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1994, 199 (03) : 1461 - 1465
  • [10] SYNERGISTIC INHIBITION BY BQ-123 AND BQ-788 OF ENDOTHELIN-1-INDUCED CONTRACTIONS OF THE RABBIT PULMONARY-ARTERY
    FUKURODA, T
    OZAKI, S
    IHARA, M
    ISHIKAWA, K
    YANO, M
    NISHIKIBE, M
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1994, 113 (02) : 336 - 338